title: Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies.
abstract: Malignancies of the central nervous system (CNS), particularly glioblastoma and brain metastases from a variety of disease sites, are difficult to treat despite advances in multimodality approaches consisting of surgery, chemotherapy, and radiation therapy (RT). Recent successes of immunotherapeutic strategies including immune checkpoint blockade (ICB)viaanti-PD-1 and anti-CTLA-4 antibodies against aggressive cancers, such as melanoma, non-small cell lung cancer, and renal cell carcinoma, have presented an exciting opportunity to translate these strategies for CNS malignancies. Moreover,viaboth localized cytotoxicity and systemic proinflammatory effects, the role of RT in enhancing antitumor immune response and, therefore, promoting tumor control is being re-examined, with several preclinical and clinical studies demonstrating potential synergistic effect of RT with ICB in the treatment of primary and metastatic CNS tumors. In this review, we highlight the preclinical evidence supporting the immunomodulatory effect of RT and discuss the rationales for its combination with ICB to promote antitumor immune response. We then outline the current clinical experience of combining RT with ICB in the treatment of multiple primary and metastatic brain tumors. Finally, we review advances in characterizing and modifying tumor radioimmunotherapy responses using biomarkers and microRNA (miRNA) that may potentially be used to guide clinical decision-making in the near future.
authors: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Baylor College of Medicine, Houston, TX, USA.
authors: Neil M
authors: NM
authors: D'Souza
authors: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.
authors: Penny
authors: P
authors: Fang
authors: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.
authors: Jennifer
authors: J
authors: Logan
authors: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.
authors: Jinzhong
authors: J
authors: Yang
authors: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.
authors: Wen
authors: W
authors: Jiang
authors: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.
authors: Jing
authors: J
authors: Li
keywords: CTLA-4; PD-1; brain metastases; brain neoplasms; glioblastoma; immune checkpoint blockade; immunotherapy; radiotherapy